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ABSTRACT 
We have identified in yeast a connection between two master regulators of cell growth: a 
biochemical one, the TORC1 protein kinase (activating protein synthesis, nutrient uptake and 
anabolism) and a biophysical one, the plasma membrane proton-pumping H+-ATPase (Pma1, 
driving nutrient uptake and regulating pH homeostasis). Raising temperature to non-
permissive values in a TOR thermosensitive mutant decreases Pma1 activity. Rapamycin, a 
TORC1 inhibitor, inhibits Pma1 dependent on its Fpr1 receptor and on protein phosphatase 
Sit4, a TORC1 effector. Mutation of either Sit4 or Tco89, a non-essential subunit of TORC1, 
decreases proton efflux, K+ uptake, intracellular pH, cell growth and tolerance to weak 
organic acids. Tco89 does not affect Pma1 activity but activates K+ transport.  
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Introduction 
 The first mechanisms controlling growth and proliferation of cells probably consisted 
on direct environmental effects, such as nutrient availability and physicochemical factors such 
as pH, temperature and water activity. In order to avoid deleterious effects of unfinished 
cellular activities, a control point named START was introduced at the G1 phase of the cell 
cycle to ensure that cell growth and division would only start under favorable conditions [1, 
2]. Finally, with the development of higher organisms, a second control named “restriction 
point”, based on hormonal compounds called “growth factors” was introduced [2-4]. 
Tumorigenic transformation of mammalian cells consists on unregulated growth and 
proliferation and the two control points, START and “restriction point”, are dysregulated in 
virtually all human cancers [2]. Accordingly, oncogenes are mutated versions of regulatory 
genes encoding component of signal transduction pathways, including membrane receptors, 
protein kinases, G proteins and transcription factors [5]. The TOR protein kinase is an 
essential regulator of growth in all eukaryotes that is activated by nutrients at START of the 
cell cycle [6, 7]. It operates through two protein complexes: TORC1 activates energy 
metabolism, nutrient uptake and synthesis of proteins, nucleotides and lipids while TORC2 
regulates actin cytoskeleton and ceramide (sphingolipid) synthesis. TORC1, but not TORC2, 
is inhibited by the natural drug rapamycin [8, 9].   
 In addition to these biochemical systems, cell growth is also regulated by biophysical 
systems energizing nutrient and K+ uptake and extruding protons for pH homeostasis [10-12]. 
Cross-talk between both kinds of systems is an important aspect of growth regulation that has 
been little investigated [12, 13]. In animal cells the Na+/H+ exchanger NHE1 is an important 
proton extrusion system and its activity is regulated by several protein kinases activated by 
growth factors [14]. The primary pump of these cells, the ouabain-sensitive Na+,K+-ATPase, 
is essential for cell growth [11, 15] and it drives nutrient uptake and Na+/H+ exchange [11]. 
This ATPase is activated by mitogens [16] but the mechanisms are mostly unknown.  
 The yeast Saccharomyces cerevisiae is a convenient model system for the study of cell 
cycle control and cancer [17] and we have investigated the regulation of its plasma membrane 
H+-ATPase (Pma1) by the TOR protein kinase. Pma1 is a proton pump essential for cell 
growth [18] and activated by glucose metabolism [19]. It generates an electrochemical proton 
gradient that energizes nutrient uptake and regulates extracellular and intracellular pH [20].  
 Our results indicate that TORC1 is required for full activity of Pma1 and this 
regulation is mediated by the protein phosphatase Sit4, a known effector of TORC1. Also, 
TORC1 subunit Tco89 activates K+ transport. Therefore, some of the growth-activating 
effects of TORC1 may be explained by activation of Pma1 and K+ transport resulting in 
increased nutrient uptake and optimal intracellular pH. This mechanism may also operate in 
animal cells, where TORC1 could activate their primary pump, the Na+,K+-ATPase. 
 
Materials and Methods 
Yeast strains and cell culture 
 Strain SH221 is a thermosensitive TOR mutant (genotype MATa leu2-3,112 trp1 ura3 
rme1 his4 HMLa ade2 his3 tor1::HIS3 tor2::ADE2/YCplac111::tor2-21ts) and strain SH100 
is the corresponding TOR wild type control (genotype MATa leu2-3,112 trp1 ura3 rme1 his4 
HMLa ade2 his3 tor1::HIS3 tor2::ADE2/YCplac111::TOR2) [21]. Strain BY4741 (genotype 
MATa his3∆1 leu2∆0 met15∆0 ura3∆0) [22] is the wild type control for the null mutants 
fpr1∆0, sit4∆0 and tco89∆0 [23].  
 Yeast cells were grown overnight in YPD medium (24) supplemented with 30 µg/ml 
adenine and incubated at either 24 or 28 ºC to early exponential phase (absorbance 0.3-0.4). 
Cultures were further incubated for 5 h under control or experimental conditions to reach 
absorbances from 1 to 3 (1.2 to 3.6 x 107 cells/ml), corresponding to late exponential phase. 
Absorbances were measured with an Ultrospec 10 of Amersham Biosciences and, when 
appropriate, cultures were diluted with water to obtain readings below 0.5. One unit 
absorbance corresponds to 1.1 mg cells/ml. Weight of cells always refers to fresh weight. 
 Normal YPD medium has a pH of 5.8-6.2 depending on autoclaving time. YPD 
medium at pH 4.1 for some experiments was made by addition (after autoclaving) 1/10 vol of 
0.5 M succinic acid-Tris base pH 3.7 buffer. 
 Growth curves of different strains were made with a Bioscreen C (Thermo Fisher 
Scientific), an instruments that allows the continuous and automated recording of cell growth 
[25]. Saturated cultures of different strains were grown for 16-24 h to an absorbance of about 
7 and used to inoculate the wells of the instrument to an initial absorbance of 0.03. 
 
Preparation of a membrane fraction enriched in plasma membranes and determination 
of Pma1 activity  
 We have determined the activity of Pma1 in membranes isolated from growing yeast 
cells because glucose in the medium is a major activator of the enzyme and removal of 
medium results in rapid inactivation [19]. Cells were grown to late exponential phase with 50 
ml YPD medium in a 250 ml flask and concentrated by centrifugation (5 min at 3000 rev/min 
in a Nahita 2655 centrifuge) and resuspension in 2 ml of supernatant. After 5 min incubation 
at growth temperature for recovery of the physiological state [19], cells were supplemented 
with 5 ml glass beads of 0.5 mm precooled at -20 ºC (BioSpec Products) and 400 µl of 
concentrated extraction buffer (0.3 M Tris-HCl pH 8.0, 0.3 M KCl and 30 mM EDTA) 
containing 2 µl 0.5 M dithiothreitol and 80 µl concentrated (x25) protease inhibitors cocktail 
(Roche Applied Science). Homogenization was effected by shaking in a vortex at top speed 
during 3 min. Liquid was recovered with a pipette and centrifuged during 5 min at 3000 
rev/min and 4 ºC (Eppendorf R5415 R centrifuge) to remove debris. Supernatant was further 
centrifuged during 20 min at 13000 rev/min and 4 ºC to obtain membranes. Pellet was 
resuspended with a Dounce homogenizer (Fisher Scientific) in 100 µl glycerol buffer (20 % 
glycerol, 10 mM Tris-HCl pH 7.6, 1 mM EDTA, 1 mM dithiothreitol), diluted with 900 µl 
cold water and centrifuged 30 min at 13000 rev/min and 4 ºC to remove inorganic phosphate 
and other contaminants. The pellet was finally homogenized with 200 µl glycerol buffer and 
kept frozen. 
 Measurement of protein concentration and assay of plasma membrane ATPase (Pma1) 
activity have been described  [26] but reactions were made in microplate wells. The ATPase 
assay buffer contains inhibitors of mitochondrial ATPase (azide), vacuolar ATPase (nitrate) 
and acid phosphatase (molybdate). Two determinations were made for every membrane 
sample, without and with 0.15 mM of Pma1 inhibitor orthovanadate. Pma1 activity 
corresponded to ATP hydrolysis resistant to azide, nitrate and molybdate and sensitive to 
vanadate and it represented more than 90 % of total ATP hydrolytic activity. Specific 
activities are given in nmoles Pi x min-1 x µg protein-1. 
 
Measurement of glucose-dependent acidification and rubidium transport 
 Wild type yeast (strain BY4741) and sit4∆ and tco89∆ mutants were grown in 20 ml 
YPD medium (100 ml flask) to late exponential phase (absorbances 1 to 3).  Then cells were 
centrifuged 5 min at 3000 rev/min, resuspended in 20 ml water and incubated 2 h at 28 ºC to 
induce K+ efflux and H+ influx and activate in this way glucose-induced acidification and K+ 
uptake [27]. After centrifugation cells were resuspended in 1 ml water.  
 The assay for acidification of external medium was made in 2 ml of 10 mM 
glycylglycine (pH 4.0) and 100 mM KCl as described [27]. Reaction was started with 50 µl 
20% glucose, calibration was made with pulses of 10 µl 10 mM HCl and pH was recorded 
with a GLP22 pH meter (Crison). Results are expressed as nmoles H+ x min-1 x mg cells-1.  
 Potassium transport was measured by the uptake of its analog rubidium, which shares 
transporters with K+ [28]. Cells were prepared as described above for the assay of external 
acidification but incubated at 20 mg/ml in a medium containing 2 % glucose and 50 mM MES 
(2-(N-morpholino)ethanesulfonic acid)-Tris pH 6.0. After 5 min at 24 ºC, RbCl was added to 
a final concentration of 5 mM and samples of 0.5 ml were taken at 0, 10 and 20 min of 
incubation with shaking at 24 ºC. After dilution with 10 ml cold 10 mM MgCl2 cells were 
centrifuged 5 min at 3000 rev/min, resuspended with 10 ml cold 10 mM MgCl2 and 
centrifuged again. Finally cells were extracted during 5 min at 95 ºC with 200 µl 10 mM 
MgCl2 centrifuged and diluted in water for assay with an atomic absorption spectrophotometer 
(SENSAA of GBC Scientific Equipment) working in emission mode. 
 
Determination of intracellular pH and potassium in yeast cells 
 Intracellular pH (pHi) was measured by the distribution of 14C-propionic acid inside 
and outside cells [10, 29]. Wild type yeast (strain BY4741) and sit4∆ and tco89∆ mutants 
were grown in 15 ml YPD medium pH 4.1 (100 ml flask) to late exponential phase 
(absorbances 1 to 3). Cells were centrifuged (5 min at 3000 rev/min) and resuspended with 3 
ml of supernatant. Then 3 µl 14C-propionic acid (100 µCi/ml and 50-60 Ci/mol; American 
Radiolabeled Chemicals) were added and incubated for 10 min to equilibrate with the pH 
gradient. Samples of 0.5 ml were taken, diluted with 10 ml cold washing solution (20 mM 
KCl and 1 mM MgCl2), filtered on glass fiber discs (Whatman GF/C) and washed on the filter 
with 10 ml cold washing solution. Filters were dried at room temperature for 30 min and 
radioactivity determined by liquid scintillation counting. Washing controls were made with 
cells treated 10 min at 95 ºC before incubation with 14C-propionic acid and had radioactivity 
values 5-10 % of experimental samples. 
 For the determination of intracellular K+ cells were grown to late exponential phase in 
YPD medium and cells from 5 ml culture were centrifuged 5 min at 3000 rev/min, 
resuspended with 5 ml cold 10 mM MgCl2 and centrifuged again to remove external K+. This 
washing step was repeated and finally cells were extracted during 5 min at 95 ºC with 500 µl 
10 mM MgCl2. After centrifugation as before, the supernatant was diluted in water for assay 
with an atomic absorption spectrophotometer (SENSAA of GBC Scientific Equipment) 




Western blot analysis of Pma1 
 Polyacrylamide gel electrophoresis (8% resolving gel) with sodium dodecylsulfate  
[30] and transfer of proteins from gel to PVDF membrane [31] were as described. Samples for 
electroforesis could not be prepared by the usual procedure of boiling in SDS because this 
aggregates Pma1. As incubation with SDS at low temperature triggers proteolysis by 
endogenous proteases, samples were first precipitated with 5 % trichloroacetic acid, washed 
with cold water and resuspended with Laemmli sample buffer at 37 ºC. Size standard was the 
PageRuler prestained Protein Ladder (Thermo Scientific) and the apparent molecular weights 
of these bands were slightly lower than theoretical. Quantification of Pma1 by western 
blotting was made with a rabbit polyclonal antibody against purified Pma1 [18]. The 
activation state of Pma1 was investigated with an antibody against the phosphorylated peptide 
corresponding to amino acids 904-917 of Pma1 and containing phosphoserine and 
phosphothreonine at positions 911 and 912, respectively [32]. Detection of the labelled blots 
was done using an Amersham ECL system (GE Heathcare Life Sciences, Buckinghamshire, 
UK) and quantification was done with the Java-based image-processing program ImageJ 
(http://rsb.info.nih.gov/ij/). Blots were first decorated with the antibody against the 
phosphorylated peptide described above, stripped by incubation for 1 h in 0.2 M glycine/HCl 
(pH 2.7), decorated with antibody against purified, and finally stained for total protein with 
Direct Blue 71. 
 
Results 
TOR is required for full activity of Pma1  
 TOR is an essential protein and a null mutant is non-viable. Therefore we have utilized 
a thermosensitive mutant generated in the laboratory of Michael N. Hall (Basel) by the 
following strategy [21]. In yeast there are two TOR genes, TOR1 and TOR2, the Tor2 protein 
can form part of the two TOR complexes (TORC1 and TORC2) but Tor1 only participates in 
TORC1. Accordingly, TOR2 is an essential gene bur TOR1 is not. Strain SH221 contains a 
null mutation in TOR1 and a thermosensitive mutation in TOR2 while the control or wild type 
strain (SH100) contains a null mutation in TOR1 but a wild type TOR2 gene. As indicated in 
Figure 1A, at 25 ºC the thermosensitive strain grows slightly less than the control strain and 
reachs the same final absorbance. At 37 ºC, however, the thermosensitive strain experiences a 
considerable decrease in growth and reaches much lower absorbance than the control strain, 
that grows normally at this temperature. 
 As indicated in Figure 1B, in the control strain the activity of Pma1 from cells grown 
at 37 ºC is 95 % of that from cells grown at 25 ºC and the difference is not statistically 
significant. On the hand, in the thermosensitive mutant the activity of Pma1 from cells grown 
at 37 ºC is 53 % of that from cells grown at 25 ºC and the difference is statistically significant. 
Therefore, thermal inactivation of TOR decreases Pma1 activity by about half. 
 
TORC1 regulates Pma1 
 As the mutant utilized for the above experiments is thermosensitive for both TOR 
complexes (TORC1 and TORC2) we have tested the effect of rapamycin, a specific inhibitor 
of TORC1 [7, 8], on Pma1 activity. In order to control for non-specific effects of the drug we 
used a mutant (fpr1∆) devoid of the rapamycin receptor and therefore resistant to specific 
effects of the drug [33, 34]. As indicated in Figure 2A rapamycin at 0.1 µM strongly inhibits 
growth in the wild type strain but no inhibition is observed in the fpr1∆ mutant. Similar 
results were obtained when the concentration of rapamycin was raised to 0.5 µM (data not 
shown).   
 Rapamycin has no effect on the Pma1 activity of the fpr1∆ mutant but it reduces the 
activity of wild type to 57 % of control cells, a similar inhibition to the one observed with the 
thermosensitive TOR mutant at non-permissive temperature (see above). These results 
indicate that TORC1 is the TOR complex required for maximum activity of Pma1.  
 
Sit4 mediates the effect of TORC1 on Pma1 
  Pma1 is a very abundant protein located at the plasma membrane [35] and its 
activation by TORC1 probably requires intermediate regulatory proteins because of the low 
abundance and poor mobility of the TOR regulatory complex [7-9]. The best-known proximal 
effectors of TORC1 are protein kinase Sch9, protein phosphatases 2A Pph21, PPG1 and Sit4 
and Tap42, a regulatory protein interacting with these phosphatases [7-9]. TAP42 is an 
essential gene [23, 36] and the phenotypes of null mutants of the other effectors indicate that 
sch9∆ [37], pph21∆ [38] and ppg1∆ [39] are acid tolerant while sit4∆ is acid sensitive [40]. A 
mutant with reduced activity of Pma1 should be acid sensitive [10, 29] and, accordingly, 
Pma1 activity in isolated membranes of the sit4∆  mutant is 55 % of wild type (Figure 3A). 
The Pma1 activity of sit4∆  is insensitive to rapamycin (less than 5 % inhibition in three 
biological repetitions, data not shown), suggesting that Sit4 mediates the effect of TORC1 on 
Pma1. Growth of sit4∆ cells is inhibited by rapamycin (Figure S1) because TORC1 has many 
important growth promoting activities in addition to activate Pma1 [6, 7]. The rate of in vitro 
ATP hydrolysis of several Pma1 mutants has been shown to correlate with the acidification 
rate of glucose metabolizing cells [41]. As indicated in Figure 3B, the cells of the sit4∆ 
mutant have reduced proton extrusion activity (47 % of wild type).  
 
Tco89, a TORC1 subunit, regulates proton efflux from cells by activating K+ transport 
  Tco89 is the only non-essential subunit of TORC1 [7] and our results indicate that its 
null mutation (tco89∆) has no significant effect on Pma1 activity of isolated membranes 
(Figure 3A). Surprisingly, this mutant exhibits a reduced acidification rate by cells, similar to 
sit4∆ mutant (Figure 3B). H+ efflux from cells depends not only on proton pumping by Pma1 
but also on electrical balance by cation uptake and anion efflux. In yeast the major 
contribution for this balance corresponds to K+ transport  [42, 43] and therefore we have 
investigated if Tco89 affects this system.  
  The results of Table 1 indicate that the rate of rubidium uptake (utilized as a tracer of 
K+ uptake [28]) in the sit4∆ and tco89∆ mutants is 51 and 53 % of wild type, respectively. As 
indicated in the same table, this reduction in uptake rate correlates with a decrease in the 
steady-state level of intracellular K+ in growing cells, which in the sit4∆ and tco89∆ mutants 
is 61 and 65 % of wild type, respectively. We can interpret these results with a model where 
Sit4 and Tco89 regulate proton efflux from yeast cells by different mechanisms: Sit4 activates 
directly Pma1, the proton pump, and indirectly K+ transport (through hyperpolarization) while 
Tco89 directly activates K+ transport and indirectly proton efflux from cells (through 
depolarization), without direct effects on Pma1.  
 
Intracellular pH of sit4∆ and tco89∆ mutants is more acidic than in wild type  
 The intracellular pH of sit4∆ and tco89∆ mutants should be more acidic than in wild 
type because of their reduced capability for proton efflux (Figure 3B). This was confirmed in 
Figure 4. For wild type cells growing at pH 4.1 pHi was 6.42, similar to previously described 
[10], and addition of acetic acid reduced this value to 6.20. The pHi of growing cells of sit4∆ 
and tco89∆ mutants was 6.25 and 6.27, respectively, and decreased to 6.05 and 6.03 in the 




Growth of sit4∆ and tco89∆ mutants is sensitive to weak organic acids  
 The decrease in H+ efflux, K+ transport and pHi of sit4∆ and tco89∆ mutants described 
above suggest that growth of these strains should be slower than wild type [10] and more 
sensitive to weak organic acids that diffuse into cells to lower pHi [40]. Actually, both 
mutants are known to have reduced growth [44] and our results provide a mechanism for this 
observation based on pHi and K+ homeostasis. Concerning organic acids, sit4∆ has been 
described to be sensitive to sorbic acid [40] but there is no information about tco89∆ . Growth 
experiments were performed in a system (Bioscreen C) that continuously register growth and 
allows the calculation of growth parameters (lag, growth rate, yield) with greater accuracy 
than previous methods. 
 As indicated in Figure 5 A and Table S1, in normal growth medium sit4∆ and 
tco89∆ have increased lag (2.5 h in both mutants versus 1.5 h in wild type) and decreased 
growth rate (70 and 86 % of wild type, respectively). Both mutants are more sensitive to 
sorbic and acetic acids than wild type (Figure 5 B and C), with a greater increase in lag and a 
greater reduction in growth rate. Growth parameters in the presence of acids were referred to 
the values for the same strain without acids (Table S1). Sorbic and acetic acids decrease 
growth rate in the control strain by 30 and 45 % and in the sit4∆ mutant by 50 and 55 %, 
respectively. Concerning the lag, sorbic and acetic acids increase it 1.8-fold in wild type but 
2.4- and 4.6-fold, respectively, in sit4∆. tco89∆ was more acid-sensitive than sit4∆ despite 
having less growth defect in normal medium. For example, sorbic and acetic acids decrease 
growth rate by 70 % and 80 %, respectively. 
  
Discussion 
 Our results indicate that growth regulation by TORC1 includes basic mechanisms of 
pH and K+ homeostasis. Cell growth requires high intracellular pH and K+ [10-12] and the 
activation of H+ extrusion and K+ uptake by TORC1 described in the present work is an 
important function of TORC1 mediated by Sit4 and Tco89, respectively. Sit4 is a proximal 
TORC1 effector and Tco89 a subunit of the complex [7].  
 Sit4 belongs to a group of type 2A protein phosphatases inhibited by TORC1 [7-9] by 
promoting binding of the inhibitory subunit Tap42 [36, 45]. Sit4 dephosphorylates and 
activates protein kinase Npr1 and transcription factor Gln3, both involved in scavenging 
secondary nitrogen sources [46, 47]. However, a mechanism where TORC1 inhibits Sit4 and 
this phosphatase were inhibitory for Pma1 is not supported by our results. If this were the case 
the sit4∆ mutant should have high Pma1 activity and we found the contrary: this mutant has 
low Pma1 activity insensitive to rapamycin, as if Sit4 were an activator of Pma1 mediating 
the positive effect of TORC1 on this proton pump. A plausible mechanism would be that, in 
the context of the proton pump, TORC1 activates Sit4 and this phosphatase activates Pma1. 
This could occur by direct dephosphorylation of Pma1 or by indirect modification of the 
proton pump after dephosphorylation of some intermediate regulator.  
 Glucose metabolism is the major factor activating Pma1 [19] and the mechanism 
involves double phosphorylation of the enzyme at Ser911 and Thr912 by some unknown 
mechanism [32, 48] as the most important modification. As indicated at Figure S2, neither 
rapamycin nor the sit4∆ mutation decrease this important phosphorylation. Other 
phosphorylations affecting Pma1 activity to a lower extent occur at Ser899 [32] and Ser507 
[49]. The last one deserved special attention because it is inhibitory and a phosphatase acting 
on phosphorylated Ser507 would activate Pma1. 
 It has recently been described that rapamycin decreases K+ accumulation in yeast cells 
independently of the Trk1 and Trk2 high affinity transporters [50]. Our results suggest that 
this effect could be mediated by the effect of TORC1 on Pma1 because inhibition of the pump 
would result in membrane depolarization and decreased K+ uptake mediated by an 
uncharacterized low-affinity transporter [51]. On the other hand, our finding that TORC1 
subunit Tco89 activates K+ transport without affecting Pma1 activity suggest that this subunit 
of unknown function is an effector of TOR specific for activation of K+ transporters by 
unknown mechanism. 
 One important aspect of these findings is that there is a reciprocal regulation between 
TORC1 and the H+ and K+ transport systems. This was first described for the TORC1-K+ pair, 
where a decrease in K+ accumulation activates TORC1 and inactivation of TORC1 decreases 
K+ accumulation [50]. In the case of H+ transport it has been described that activation of 
Pma1 by glucose increases TORC1 activity and that this effect is mediated by an increase in 
intracellular pH [52]. Our results show the reciprocal regulation, TORC1 regulates Pma1. 
 As a final consideration, it must be pinpointed that our work has uncovered a 
connection between two essential regulators of cell growth, TORC1 and Pma1, and that this 
add a novel perspective to the central problem of growth control. For example we predict that 
this regulation of the proton pump by TORC1 would be general in organisms with a 
chemiosmotic circuit of protons (such as fungi and plants) and that in animal cells, with a 
chemiosmotic circuit of sodium, TORC1 will regulate the sodium-potassium pumping 
ATPase. 
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Table 1. Altered K+ homeostasis in sit4∆ and tco89∆ mutants 
Rubidium uptake was used as tracer for K+ uptake in cells starved in water as 
described in methods to partially deplete internal K+. Intracellular K+ was 
determined in growing cells at late exponential phase. Results are the average of 
three experiments with its standard error. 
Strain Rubidium uptake rate 
nmoles / mg cells x 10 min 
Intracellular K+ levels 
nmoles/mg cells 
BY4741 wild type 1.37 ± 0.02 68.0 ± 2.5 
sit4∆ mutant 0.70 ± 0.01 41.5 ± 1.2 








Figure 1. Inhibition of TOR in a thermosensitive mutant decreases Pma1 activity. A: typical 
growth of wild type yeast (strain SH100, wt, circles) and thermosensitive mutant (strain 
SH221; torts, squares) at either 25 ºC (open symbols) or 37 ºC (filled symbols) in YPD 
medium. B: Pma1 activity determined in membranes isolated from cells (wild type and torts 
mutant) grown for 5 h at either 25 ºC (open bars) or 37 ºC (filled bars) in YPD medium. Pma1 
activity is expressed in nmoles Pi x min-1 x µg protein-1. The experiment has been repeated 
three times (3 biological repetitions) and error bars correspond to standard errors. Asterisk 
above a filled bar indicates a significant difference (p < 0.05, Student’s t-test) with control 
(adjacent open bar). 
 
 
                            
 
Figure 2. Rapamycin, a TORC1 inhibitor, decreases Pma1 activity in a manner dependent on 
rapamycin receptor Fpr1. A: growth of wild type yeast (strain BY4741, wt, circles) and fpr1∆ 
mutant (squares) in the absence of rapamycin (open symbols) and with 0.1 µM rapamycin 
(filled symbols) in YPD medium. B: Pma1 activity determined in membranes isolated from 
cells (wild type and fpr1∆ mutant) grown for 5 h in the absence (open bars) or presence (filled 
symbols) of 0.1 µM rapamycin in YPD medium. Pma1 activity is expressed in nmoles Pi x 
min-1 x µg protein-1. All experiments have been repeated three times (3 biological repetitions) 
and error bars correspond to standard errors. Asterisk above a filled bar indicates a significant 












Figure 3. Effect of null mutations in TORC1 effector Sit4 and TORC1 subunit Tco89 on 
Pma1 activity and proton efflux from cells. (A) Pma1 activity in isolated membranes from 
control strain (BY4741, wt), sit4∆ and tco89∆ mutants growing on YPD medium. Ordinate 
units are nmoles Pi x min-1 x µg protein-1. (B) Glucose-dependent acidification of external 
medium in cells from wild type (control strain BY4741; circles), sit4∆ (triangles) and tco89∆ 
(squares) mutants. Initial rates of acidification (expressed as nmoles H+ x min-1 x mg cells-1) 
are indicated at the right. All experiments have been repeated three times (3 biological 
repetitions) and error bars (in A) and “± values” (in B) correspond to standard errors. Asterisk 




Figure 4. Intracellular pH of sit4∆ and tco89∆ mutants is more acidic than in wild type. 
Intracellular pH was measured in growing cultures al late exponential phase by the 
distribution of 14C-propionic acid as described in Methods. Time 0 corresponds to the culture 
before addition of acetic acid at 60 mM to induce intracellular acidification. Times 20, 40, 60 
and 120 min correspond to incubation times in the presence of acetic acid. The experiment 
has been repeated three times (3 biological repetitions) and error bars correspond to standard 
errors. All values of sit4∆ and tco89∆ mutants have a significant difference (p < 0.05, 






Figure 5. Growth of BY4741 and sit4∆ and tco89∆ mutants in YPD medium pH 4.1 (A) and in this 
medium supplemented with 1.5 mM sorbic acid (B) and 60 mM acetic acid (C). A typical 




Supplementary Figure S1. Growth of sit4∆ mutant is inhibited by rapamycin. 
Supplementary Figure S2. Rapamycin treatment and the sit4∆ mutation slightly increase the 
phosphorylation of the major activation site of Pma1. A: staining of blotted proteins by Direct 
Blue 71. First lane corresponds to size standards and the molecular weights of the bands are 
indicated in kDa. B: immunodetection of phosphorylation of the major activation site of 
Pma1, the double phosphorylation in Ser911 and Thr912 (Anti pSpT). C: immunodetection of 
Pma1 protein. In all panels lanes 1 correspond to membranes from strain BY4741 grown 
under normal conditions, lane 2 to membranes from BY4741 treated with rapamycin and lane 
3 to membranes from the sit4∆ mutant. Results of a typical experiment are shown. Statistical 
data after densitometry (Image J) of three experiments are shown in the table. To correct for 
differences in loading of the lanes, the signal of the double phosphorylation in Ser911 and 
Thr912 and of Pma1 protein were normalized with the signal of a protein band in panel A 
with molecular weight about 120 kDa (just above the Pma1 band, see asterisk). Values in the 






Supplementary Table S1. Growth parameters of control strain (BY4741) and sit4∆ and 
tco89∆ mutants in the presence of weak organic acids. Absolute values are given for every 
strain in the first column (YPD medium adjusted to pH 4.1 and no more additions). In the 
columns corresponding to media supplemented with acetic or sorbic acids, values for each 
strain are relative to those of the same strain in the first column.  Results are the average of 
three experiments like the one shown in Figure 4. The standard error ranged from 1/20 to 1/10 






 YPD pH 4.1 + acetic acid 
(60 mM) 
+ sorbic acid  
 (1.5 mM) 
Strain lag    rate     yield 
h      h-1       absorb. 
lag    rate     yield  
(% of YPD pH 4.1)   
lag     rate    yield 
(% of YPD pH 4.1) 
BY4741 1.5   0.44     2.8 185     55      65      180      72       75       
sit4∆ 2.5   0.31     2.9 457     45      41 240      52       62          
tco89∆ 2.5   0.38     3.1 440     21      23 240      31       45 
